Does Famotidine Reduce the Risk of Progression to Severe Disease, Death, and Intubation for COVID-19 Patients? A Systemic Review and Meta-Analysis

BACKGROUND: Famotidine was reported to potentially provide benefits to Coronavirus Disease 2019 (COVID-19) patients. However, it remains controversial whether it is effective in treating COVID-19. AIMS: This study aimed to explore whether famotidine use is associated with reduced risk of the severit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chenyu, Chen, Yue, Hu, Lei, Wu, Yile, Liang, Mingming, Ayaz Ahmed, Mubashir, Bhan, Chandur, Guo, Zhichun, Yang, Hongru, Zuo, Yijing, Yan, Yue, Zhou, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903022/
https://www.ncbi.nlm.nih.gov/pubmed/33625613
http://dx.doi.org/10.1007/s10620-021-06872-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903022/
https://www.ncbi.nlm.nih.gov/pubmed/33625613
http://dx.doi.org/10.1007/s10620-021-06872-z

Ejemplares similares